Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Infections 1Granuloma 1Empyema 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Cone-Beam Computed Tomography × Clear all
NCT02337465 2021-02-23

KV-CBCT and Ultrasound Imaging in Guiding Radiation Therapy in Patients With Prostate, Liver, or Pancreatic Cancer

Case Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Prostatic Neoplasms

NCT01287013 2018-01-05

Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided Procedures

National Institutes of Health Clinical Center (CC)

Phase NA Terminated
87 enrolled 10 charts

Empyema, Granuloma, Infections, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡